Google News – FDA (biotech/pharma) External News
Biotechnology Articles
Google News – Clinical Trials External News
How To Read A Biotech Clinical Trial Result: P-values, Endpoints, And Investor Implications - RTTNews
Google News – Cardiology External News
ESC26: AstraZeneca's heart failure drug shows promise in ph. 2 trial - Fierce Biotech
Google News – FDA (biotech/pharma) External News
EIT Pharma Raises $35 Million Series A to Advance Lonafarnib - citybiz.co
Google News – FDA (biotech/pharma) External News
B. Braun adds to a string of IV solution recalls in US - fiercepharma.com
Google News – FDA (biotech/pharma) External News
EIT Pharma raises $35M Series A to push hepatitis D drug toward approval - Dealroom
Google News – FDA (biotech/pharma) External News
FDA clears Takeda, Protagonist's first-in-class PV drug - Pharmaphorum
Google News – Pharmaceuticals External News
Minapharm Pharmaceuticals Says CEPI Grants Up To $16.5 Mln Funding To Advance Ebolavirus Vaccine - TradingView
Google News – Biopharma External News
RDHL Stock Volatility Draws Trader Focus As Biotech Reprices - stockstotrade.com
Google News – FDA (biotech/pharma) External News
On the 'cusp,' PharmaEssentia gains FDA label expansion for Besremi - Fierce Pharma
Google News – Oncology External News
Verastem shifts from speculative biotech to com... - Pluang
Google News – FDA (biotech/pharma) External News
Cronus Pharma Launches FDA-Approved Robenacoxib Injection for Veterinary Use - Machine Maker
Google News – Biotech Funding External News
Biotech Startup Investment Held Steady Even As AI Funding Surged - Crunchbase News
Google News – FDA (biotech/pharma) External News
Jemperli accepted for priority review by US FDA - PharmaTimes
Google News – Clinical Trials External News

